A citation-based method for searching scientific literature


List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Exenatide mitigated diet-induced vascular aging and atherosclerotic plaque growth in ApoE-deficient mice under chronic stress.
Guang Yang, Yanna Lei, Aiko Inoue, Limei Piao, Lina Hu, Haiying Jiang, Takeshi Sasaki, Hongxian Wu, Wenhu Xu, Chenglin Yu,[...]. Atherosclerosis 2017
39
100


Intensive glucose control and macrovascular outcomes in type 2 diabetes.
F M Turnbull, C Abraira, R J Anderson, R P Byington, J P Chalmers, W C Duckworth, G W Evans, H C Gerstein, R R Holman, T E Moritz,[...]. Diabetologia 2009
750
100

Inhibition of plaque progression and promotion of plaque stability by glucagon-like peptide-1 receptor agonist: Serial in vivo findings from iMap-IVUS in Watanabe heritable hyperlipidemic rabbits.
Mitsumasa Sudo, Yuxin Li, Takafumi Hiro, Tadateru Takayama, Masako Mitsumata, Masashi Shiomi, Masahiko Sugitani, Taro Matsumoto, Hiroyuki Hao, Atsushi Hirayama. Atherosclerosis 2017
28
100

Adiponectin improves NF-κB-mediated inflammation and abates atherosclerosis progression in apolipoprotein E-deficient mice.
Xuemei Wang, Qingjie Chen, Hongwei Pu, Qin Wei, Mingjun Duan, Chun Zhang, Tao Jiang, Xi Shou, Jianlong Zhang, Yining Yang. Lipids Health Dis 2016
47
100

Antiatherogenic effects of liraglutide in hyperglycemic apolipoprotein E-null mice via AMP-activated protein kinase-independent mechanisms.
Masakazu Koshibu, Yusaku Mori, Tomomi Saito, Hideki Kushima, Munenori Hiromura, Michishige Terasaki, Michiya Takada, Tomoyasu Fukui, Tsutomu Hirano. Am J Physiol Endocrinol Metab 2019
8
100


Exenatide (a GLP-1 agonist) improves the antioxidative potential of in vitro cultured human monocytes/macrophages.
Łukasz Bułdak, Krzysztof Łabuzek, Rafał Jakub Bułdak, Grzegorz Machnik, Aleksandra Bołdys, Bogusław Okopień. Naunyn Schmiedebergs Arch Pharmacol 2015
20
100

Exenatide protects against hypoxia/reoxygenation-induced apoptosis by improving mitochondrial function in H9c2 cells.
Guanglei Chang, Dongying Zhang, Jian Liu, Peng Zhang, Lin Ye, Kai Lu, Qin Duan, Aihua Zheng, Shu Qin. Exp Biol Med (Maywood) 2014
36
100

Liraglutide Attenuates Preestablished Atherosclerosis in Apolipoprotein E-Deficient Mice via Regulation of Immune Cell Phenotypes and Proinflammatory Mediators.
Robyn Bruen, Seán Curley, Sarina Kajani, Gina Lynch, Marcella E O'Reilly, Eugène T Dillon, Eoin P Brennan, Mary Barry, Stephen Sheehan, Fiona C McGillicuddy,[...]. J Pharmacol Exp Ther 2019
13
100


Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial.
Richard E Pratley, Vanita R Aroda, Ildiko Lingvay, Jörg Lüdemann, Camilla Andreassen, Andrea Navarria, Adie Viljoen. Lancet Diabetes Endocrinol 2018
225
100

Exendin-4 promotes the vascular smooth muscle cell re-differentiation through AMPK/SIRT1/FOXO3a signaling pathways.
Zihan Liu, Mengqian Zhang, Tengfei Zhou, Qiang Shen, Xiaomei Qin. Atherosclerosis 2018
14
100

Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.
Juan P Frías, Melanie J Davies, Julio Rosenstock, Federico C Pérez Manghi, Laura Fernández Landó, Brandon K Bergman, Bing Liu, Xuewei Cui, Katelyn Brown. N Engl J Med 2021
37
100

Regulation and involvement of matrix metalloproteinases in vascular diseases.
Matthew Amin, Sathnur Pushpakumar, Nino Muradashvili, Sourav Kundu, Suresh C Tyagi, Utpal Sen. Front Biosci (Landmark Ed) 2016
41
100

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
Søren L Kristensen, Rasmus Rørth, Pardeep S Jhund, Kieran F Docherty, Naveed Sattar, David Preiss, Lars Køber, Mark C Petrie, John J V McMurray. Lancet Diabetes Endocrinol 2019
399
100


Glucagon-like peptide-1 (GLP-1) induces M2 polarization of human macrophages via STAT3 activation.
Daisuke Shiraishi, Yukio Fujiwara, Yoshihiro Komohara, Hiroshi Mizuta, Motohiro Takeya. Biochem Biophys Res Commun 2012
87
100

Glucagon-Like Peptide-1 Receptor Agonist Attenuates Autophagy to Ameliorate Pulmonary Arterial Hypertension through Drp1/NOX- and Atg-5/Atg-7/Beclin-1/LC3β Pathways.
Yi-Chia Wu, Wei-Ting Wang, Su-Shin Lee, Yur-Ren Kuo, Ya-Chin Wang, Shih-Jung Yen, Mei-Yueh Lee, Jwu-Lai Yeh. Int J Mol Sci 2019
12
100

Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus.
Thomas A Zelniker, Stephen D Wiviott, Itamar Raz, KyungAh Im, Erica L Goodrich, Remo H M Furtado, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn,[...]. Circulation 2019
271
100

Stimulation of glucagon-like peptide-1 receptor through exendin-4 preserves myocardial performance and prevents cardiac remodeling in infarcted myocardium.
Megan DeNicola, Jianfeng Du, Zhengke Wang, Naohiro Yano, Ling Zhang, Yigang Wang, Gangjian Qin, Shougang Zhuang, Ting C Zhao. Am J Physiol Endocrinol Metab 2014
39
100

The incretin pathway as a therapeutic target in diabetic kidney disease: a clinical focus on GLP-1 receptor agonists.
Michaël J B van Baar, Annemarie B van der Aart, Klaas Hoogenberg, Jaap A Joles, Hiddo J L Heerspink, Daniël H van Raalte. Ther Adv Endocrinol Metab 2019
11
100

Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice.
Teruo Jojima, Kohsuke Uchida, Kazumi Akimoto, Takanori Tomotsune, Kazunori Yanagi, Toshie Iijima, Kunihiro Suzuki, Kikuo Kasai, Yoshimasa Aso. Atherosclerosis 2017
45
100

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.
Adrian F Hernandez, Jennifer B Green, Salim Janmohamed, Ralph B D'Agostino, Christopher B Granger, Nigel P Jones, Lawrence A Leiter, Anne E Rosenberg, Kristina N Sigmon, Matthew C Somerville,[...]. Lancet 2018
634
100

Incretins and Lipid Metabolism.
Vasilis Tsimihodimos, Moses Elisaf. Curr Med Chem 2018
8
100

The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE-/- and LDLr-/- Mice by a Mechanism That Includes Inflammatory Pathways.
Günaj Rakipovski, Bidda Rolin, Jane Nøhr, Ib Klewe, Klaus S Frederiksen, Robert Augustin, Jacob Hecksher-Sørensen, Camilla Ingvorsen, Joseph Polex-Wolf, Lotte Bjerre Knudsen. JACC Basic Transl Sci 2018
81
100



Cardiovascular actions of incretin-based therapies.
John R Ussher, Daniel J Drucker. Circ Res 2014
236
100

Exendin-4 Prevents Vascular Smooth Muscle Cell Proliferation and Migration by Angiotensin II via the Inhibition of ERK1/2 and JNK Signaling Pathways.
Kosuke Nagayama, Yoji Kyotani, Jing Zhao, Satoyasu Ito, Kentaro Ozawa, Francesco A Bolstad, Masanori Yoshizumi. PLoS One 2015
35
100

Effects of GLP-1 on appetite and weight.
Meera Shah, Adrian Vella. Rev Endocr Metab Disord 2014
89
100


Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
Marc A Pfeffer, Brian Claggett, Rafael Diaz, Kenneth Dickstein, Hertzel C Gerstein, Lars V Køber, Francesca C Lawson, Lin Ping, Xiaodan Wei, Eldrin F Lewis,[...]. N Engl J Med 2015
100

Effects on cardiovascular risk factors of weight losses limited to 5-10.
Joshua D Brown, Joanna Buscemi, Vanessa Milsom, Robert Malcolm, Patrick M O'Neil. Transl Behav Med 2016
37
100

Is there a Chance to Promote Arteriogenesis by DPP4 Inhibitors Even in Type 2 Diabetes? A Critical Review.
Srinivasan Vedantham, Anna-Kristina Kluever, Elisabeth Deindl. Cells 2018
7
100

Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4.
Masayuki Arakawa, Tomoya Mita, Kosuke Azuma, Chie Ebato, Hiromasa Goto, Takashi Nomiyama, Yoshio Fujitani, Takahisa Hirose, Ryuzo Kawamori, Hirotaka Watada. Diabetes 2010
355
100

Mechanisms of foam cell formation in atherosclerosis.
Dimitry A Chistiakov, Alexandra A Melnichenko, Veronika A Myasoedova, Andrey V Grechko, Alexander N Orekhov. J Mol Med (Berl) 2017
194
100


Incretin hormones: Their role in health and disease.
Michael A Nauck, Juris J Meier. Diabetes Obes Metab 2018
198
100

Hypoglycemia, Cardiovascular Outcomes, and Death: The LEADER Experience.
Bernard Zinman, Steven P Marso, Erik Christiansen, Salvatore Calanna, Søren Rasmussen, John B Buse. Diabetes Care 2018
52
100


CV Protection in the EMPA-REG OUTCOME Trial: A "Thrifty Substrate" Hypothesis.
Ele Ferrannini, Michael Mark, Eric Mayoux. Diabetes Care 2016
512
100

Effects of GLP-1 in the kidney.
Jeppe Skov. Rev Endocr Metab Disord 2014
48
100

Glucagon-like peptide-1 receptor mediated control of cardiac energy metabolism.
Rami Al Batran, Malak Almutairi, John R Ussher. Peptides 2018
9
100

Phenotypic switching of vascular smooth muscle cells in the 'normal region' of aorta from atherosclerosis patients is regulated by miR-145.
Yu-Nan Zhang, Bao-Dong Xie, Lu Sun, Wei Chen, Shu-Lin Jiang, Wei Liu, Fei Bian, Hai Tian, Ren-Ke Li. J Cell Mol Med 2016
67
100

LOX-1, a bridge between GLP-1R and mitochondrial ROS generation in human vascular smooth muscle cells.
Yao Dai, Federico Mercanti, Dongsheng Dai, Xianwei Wang, Zufeng Ding, Naga Venkata Pothineni, Jawahar L Mehta. Biochem Biophys Res Commun 2013
30
100

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
100

Exenatide exhibits anti-inflammatory properties and modulates endothelial response to tumor necrosis factor α-mediated activation.
Wojciech Garczorz, Enrique Gallego-Colon, Agnieszka Kosowska, Agnieszka Kłych-Ratuszny, Michał Woźniak, Wiesław Marcol, K J Niesner, Tomasz Francuz. Cardiovasc Ther 2018
14
100

A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model.
Tracey Gaspari, HongBin Liu, Iresha Welungoda, Yunshan Hu, Robert E Widdop, Lotte B Knudsen, Richard W Simpson, Anthony E Dear. Diab Vasc Dis Res 2011
116
100

Protective Effects of Glucagon-like Peptide 1 on Endothelial Function in Hypertension.
Limei Liu, Jian Liu, Yu Huang. J Cardiovasc Pharmacol 2015
17
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.